Pharma & Biotech

After a challenging period that saw its valuation cut in half, gene-editing specialist Intellia Therapeutics appears to be building a...

A landmark legal settlement has fundamentally reshaped the long-term financial outlook for pharmaceutical giant AbbVie. The company has successfully safeguarded...

ImmunityBio's stock experienced a significant boost, climbing more than 8%, following the presentation of compelling new data from its Phase...

PepGen Inc. shares are experiencing significant price movements, having gained nearly 10% in a recent session. Over a two-week span,...

The investment community is closely monitoring Incyte Corporation as a significant regulatory milestone approaches. A forthcoming decision by the U.S....

Sarepta Therapeutics shares closed Friday's trading session down 2.9 percent at $17.39, a decline that occurred despite a positive earnings...

BioNTech SE finds its equity caught in a significant downdraft, pressured not by its fundamentals but by emerging political risks...

Investors in Xeris Biopharma Holdings, Inc. are currently weighing contradictory market signals that present a compelling investment puzzle. On one...

Investor sentiment surrounding Ocular Therapeutix is currently a study in contrasts. The biopharmaceutical company finds itself at a crossroads, buoyed...

Eli Lilly confronts significant challenges this week as a US appellate court upheld a substantial $184 million penalty against the...